Pfizer study shows risk of cholesterol pill switch
50669
Patients switching from Pfizer's branded cholesterol pill Lipitor to Merck & Co's Zocor -- now available as a cheap generic -- are more likely to have a heart attack or die, according to a Pfizer-backed study.
640747
People who significantly cut their cholesterol levels with statins may raise the risk of cancer, a study says.
310604
An unusual study enrolling only black Americans showed a more powerful statin drug worked better to lower cholesterol than a rival brand, researchers said on Tuesday.
714184
Patients could cut risk by taking a cholesterol-lowering drug even if they have normal cholesterol levels, study finds.
441497
An aggressive, high-dose regimen of cholesterol-lowering drugs within days after a heart attack may reduce further heart problems, says a new large-scale study.
143733
The move follows recent studies suggesting that the medications might cause heart attacks.
729940
NEW YORK, OCTOBER 15 : PFIZER Inc. on Friday said two clinical trials showed patients taking its anti-inflammatory drug Bextra, had a higher risk of cardio-vascular events during high-risk coronary bypass surgery.
336236
U.S. regulators said on Friday they would review a study showing a Merck and Schering-Plough cholesterol drug worked no better than a generic in preventing the build-up of arterial plaque.
704575
NEW YORK -- A new study has linked painkillers Vioxx, Celebrex, and Bextra to increased cardiovascular risk, reinforcing findings of other trials that have already sparked concern over the safety of a popular category of drugs.
32044
High doses of Zocor provide no benefits in preventing new problems in heart attack patients: study. MUNICH  - Merck&#39;s anti-cholesterol drug Zocor suffered a setback after a major study found high
438179
Shares of Pfizer Inc. slipped on Wednesday, following reports that a study had likened the companyâs Bextra arthritis drug to Merck&#39;s Vioxx in terms of its cardiovascular risks.
84184
As the Food and Drug Administration prepares to make recommendations about Pfizer&#39;s (PFE:NYSE - news - research) Celebrex, the companies that ultimately pay for the drug aren&#39;t leaping to conclusions merely because one recent study showed patients taking
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
41032
St Petersburg - There&#39;s a new warning out about another popular pain pill that could be dangerous for your heart. Drug maker Pfizer says recent studies show an increased risk of heart problems in people who take Celebrex.
296678
Cholesterol-lowering statins, a  popular class of drugs that includes Pfizer Inc.'s Lipitor, may  slow the progression of Alzheimer's disease, according to  results from a small study presented on Tuesday.
525567
Drug maker Merck & Co. Inc.  urged U.S. advisers on Thursday to approve the first over-the-counter sales of a cholesterol-lowering pill, but regulators questioned if consumers would use it properly.
75596
Pfizer yesterday said new data showed the painkiller, Celebrex, more than doubled the risk of heart attacks, sending the US drugmaker&#39;s shares plunging.